News

Get FREE PGS-NGS for Your Clinic – only at ESHRE 2017

We would like to invite you to our stand – F01 at ESHRE Conference in Geneva. INVICTA Genetics highest quality has been verified by external quality […]

Read more

ESHRE 2017 – Geneva

INVICTA Genetic Laboratory is pleased to invite you to visit our stand during the 33st Congress of the European Society of Human Reproduction and Embryology (ESHRE) […]

Read more

DNA tests – only in a proven laboratory

The analysis of genetic predispositions for diseases is becoming the key element of the modern preventive healthcare. There is even a new branch of knowledge being […]

Read more

16th International Conference on Preimplantation Genetic Diagnosis – Invitation

Already in less than two weeks, during the 16th International PGD Conference organized by the PGDIS (Preimplantation Genetic Diagnosis International Society), INVICTA Genetics Laboratory will present […]

Read more

INVICTA genetic embryo testing with the international quality certificate

Mutations in chromosomes, i.e. translocations or insertions – although in a given person most often do not cause health problems – can increase significantly the risk […]

Read more
woman age

PGS Preimplantation Diagnosis in the treatment of infertility

PGS Preimplantation Diagnosis allows to eliminate the risk of genetic defects in a child even before a woman gets pregnant. By examining the embryo’s cells, the […]

Read more

16th International Conference on Preimplantation Genetic Diagnosis

INVICTA GENETICS is pleased to invite you to visit our stand during the 16th International Conference on Preimplantation Genetic Diagnosis, organized by the Preimplantation Genetic Diagnosis […]

Read more

Noninvasive prenatal testing – course of a diagnostic procedure

Noninvasive prenatal testing detects the most common foetal chromosomal aberrations: trisomy of chromosomes 13, 18 and 21 and numerical aberrations of sex chromosomes. An additional option […]

Read more

NIPT – non-invasive prenatal testing

NIPT – non-invasive prenatal test is used to assess the risk of chromosomal aberrations that are the most commonly observed in a fetus. It allows for […]

Read more

Karyotype of a miscarried foetus

Early pregnancy loss is often an effect of embryo genetic abnormalities. These abnormalities may come from parents’ reproductive cells or from mutations occurring during divisions of […]

Read more

Whole gene NGS sequencing

    Test BRCA1 i BRCA2™ The BRCA1 and BRCA2 test is a genetic screening test performed using the Next Generation Diagnosis (NGS) technique. It aims […]

Read more

International Quality Control in Preimplantation Genetic Diagnosis

Since 2013, a new tool in molecular biology – Next Generation Sequencing (NGS) – has been used for preimplantation genetic diagnosis. This technology is used to […]

Read more

PGD TRS™ Pre-implantation diagnosis for translocations

PGD TRS™ preimplantation diagnosis allows examining the cells collected from embryos for the presence of abnormalities resulting from balanced reciprocal translocations in parents. This testing technique […]

Read more

Research and Training Symposium of the Polish Society for Reproductive Medicine 7-8th October, Warsaw

On 7-8 October 2016, INVICTA Research Team will participate in the Research and Training Symposium of the Polish Society for Reproductive Medicine and Embryology and the […]

Read more